Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Struggling Acorda is Exploring a Sale, Shares Jump January 7, 2018 Nabriva's Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials September 17, 2017 SoCal's USGI Medical Names Former ConMed Exec as CEO April 18, 2017
